Open AccessPD28-09 ABNORMAL HER2 AND HER3 SIGNALLING IN PROSTATE CANCER: POTENTIALS FOR CLINICAL APPLICATION.
Author(s) -
K. Nageswara Rao,
Massar Alsamraae,
Luke Gaughan,
Craig Robson,
Stuart McCracken
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.396
Subject(s) - lncap , prostate cancer , lapatinib , medicine , enzalutamide , androgen receptor , cancer research , cancer , pi3k/akt/mtor pathway , prostate , trastuzumab , signal transduction , breast cancer , biology , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom